dipity

Recent Event Highlights: Dissidents nominate 5 to VaxGen board, VaxGen Restructures Board of Directors, VaxGen sells experimental vaccine to rival, VaxGen Shares Fall on Vaccine Uncertainty, and 4 more...

Created by dipity on Sep 24, 2009

Last updated: 09/24/09 at 05:08 AM

• Self Bank: Hoy cumbre del G-20
  Sep 24, 2009 2:15 AM

  por debajo en ingresos. También el sector farmacéutico es protagonista al conocerse que Sanofi-Aventis ha logrado que una vacuna contra el virus del sida sea efectiva. La vacuna está formada por Alvac, de Sanofi, y Aidsvax, un producto de VaxGen. Por otro lado, Astrazeneca podría cotizar a la baja debido a la rebaja de recomendación hasta neutral por parte de Goldman, tras saltar temores sobre la posibilidad de que los genéricos mermen las ventas de la compañía. El sector de automoción ...

• Dissidents nominate 5 to VaxGen board
  Sep 22, 2009 2:58 PM

  Excerpt ...of VaxGen’s outstanding common stock — said the nominees would immediately distribute $10,000 cash to shareholders, terminate VaxGen’s property lease, protect the company’s rights to royalty payments and consider reducing VaxGen to a “public shell.” VaxGen... Source Info San Francisco Business Times
  http://feeds.bizjournals.com/~r/bizj_sanfrancisco/~3/HsrRbVhvr1c/daily48.html

• VaxGen Restructures Board of Directors
  May 22, 2008 4:37 PM

  Excerpt No data currently available. No data currently available. When a business borrows money so it can reinvest it in hopes of getting a higher return, it's called leverage. Using loaned money, the company can make larger investments, and, therefore, Source Info FOX Business
  http://feeds.foxbusiness.com/~r/foxbusiness/latest/~3/296256040/

• VaxGen sells experimental vaccine to rival
  May 5, 2008 10:29 AM

  Excerpt VaxGen, the South San Francisco company that has been reduced to a shadow of its former self after losing a $877.5 million federal contract to develop an anthrax vaccine, announced today that it has sold the experimental vaccine to its chief rival. Source Info The San Jose Mercury News
  http://www.mercurynews.com/news/ci_9159012?source=rss

• MPM BioEquities Demands VaxGen Drop Merger Plan with Raven
  Dec 12, 2007 7:25 AM

  Excerpt SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Dec 12, 2007 - MPM BioEquities Advisers ("MPM"), a VaxGen Inc. (Pink Sheets:VXGN) shareholder, in a letter to VaxGen's CEO and its board of directors, has requested the company not to pursue its Source Info Drugs.com
  http://feeds.drugs.com/~r/Drugscom-HeadlineNews/~3/199254879/mpm-bioequities-demands-vaxgen-drop-merger-plan-raven-7385.html

• Decision to kill Vaxgen contract could help Avecia Biotechnology
  Dec 20, 2006 4:18 PM

  Excerpt WASHINGTON (AP) -- The U.S. government's decision to terminate an $877 million contract with VaxGen Inc. to develop a new anthrax vaccine could prove a windfall for Avecia Biotechnology, a private UK-based company which has already received funding to Source Info Chosun Ilbo Related Topics
  http://hosted.ap.org/dynamic/stories/V/VAXGEN_CONTRACT_AVECIA_CAOL-?SITE=CAANR&SECTION=HOME&TEMPLATE=DEFAULT

• VaxGen Shares Fall on Vaccine Uncertainty
  May 11, 2006 6:04 AM

  Excerpt Shares of VaxGen Inc. plunged 37 percent yesterday after the company complained about new government requirements in its contract to produce an anthrax vaccine, characterizing them as so onerous and time-consuming the company isn't sure it will Source Info The Washington Post Related Topics
  http://www.washingtonpost.com/wp-dyn/content/article/2006/05/10/AR2006051002171.html?nav=rss_business

• Commentary: Medical Trial Recruitment
  Feb 27, 2003 5:54 PM

  Excerpt ...commentator Joe Wright worked for a government-sponsored HIV vaccine trial network as a community educator. Later, he was on VaxGen's community advisory board. When VaxGen was recruiting volunteers for their trial, they mainly signed up white, gay men. Today,... Source Info NPR
  http://www.npr.org/templates/story/story.php?storyId=1174583